IL1B and colitis: In addition, I3C therapy significantly reduced the mRNA expression of proinflammatory cytokines IL‐1β (Figures S7K, Supporting Information), IFNγ (Figure S7L, Supporting Information), and TNFα (Figure S7M, Supporting Information) in DSS‐induced colitis mice.